PTC Therapeutics, Inc.
PTCT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001070081
In the last 90 days, PTC Therapeutics, Inc. insiders filed 0 open-market purchases and 12 sales; 382 institutions reported holding it in 13F filings for Q2 2026, worth $8.20B in total; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding PTC Therapeutics, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Of which not filed for Q3 2021 | Q3 2021 | Change |
|---|---|---|---|---|
| Holders | 183 | 2 | 184 | +3 |
| Shares | 74.2M | 459.2K | 74.6M | +890.3K (+1.2%) |
| Value | $3.13B | $19.4M | $2.77B | −$337.7M (−10.9%) |
2 institutions that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (22)
Institutions that held PTC Therapeutics, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Camber Capital Management LP | 750,000 | $27.9M | 1.04% |
| Asymmetry Capital Management, L.P. | 215,985 | $8.04M | 4.83% |
| Engineers Gate Manager LP | 27,116 | $1.01M | 0.06% |
| Twinbeech Capital LP | 20,705 | $770.0K | 0.05% |
| Gsa Capital Partners LLP | 17,239 | $641.0K | 0.07% |
| American Century Companies Inc | 13,170 | $490.0K | 0.00% |
| Walleye Trading LLC | 12,841 | $478.0K | 0.01% |
| Jefferies Group LLC | 12,600 | $468.8K | 0.01% |
| Jane Street Group, LLC | 11,576 | $431.0K | 0.00% |
| Zebra Capital Management LLC | 10,751 | $400.0K | 0.48% |
| Martingale Asset Management L P | 8,117 | $303.0K | 0.00% |
| Creative Planning | 7,395 | $275.0K | 0.00% |
| LSP Investment Advisors, LLC | 6,500 | $242.0K | 0.10% |
| Stifel Financial Corp | 5,774 | $215.0K | 0.00% |
| Neo Ivy Capital Management | 1,320 | $67.0K | 0.08% |
| Dark Forest Capital Management LP | 310 | $12.0K | 0.00% |
| Allworth Financial LP | 282 | $10.0K | 0.00% |
| Caption Management, LLC | 263 | $10.0K | 0.00% |
| Smith Group Asset Management, LLC | 70 | $3.00K | 0.00% |
| Bell Investment Advisors, Inc | 65 | $2.00K | 0.00% |
| Signaturefd, LLC | 23 | $1.00K | 0.00% |
| Meridian Wealth Partners, LLC | 32 | $1.00K | 0.00% |
Sold out (19)
Institutions that held PTC Therapeutics, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Two Sigma Investments, LP | 74,489 | $3.15M |
| Dimensional Fund Advisors LP | 64,228 | $2.71M |
| Schonfeld Strategic Advisors LLC | 60,100 | $2.54M |
| Gyon Technologies Capital Management, LP | 43,971 | $1.86M |
| Magnetar Financial LLC | 24,455 | $1.03M |
| Voloridge Investment Management, LLC | 23,040 | $974.0K |
| ClariVest Asset Management LLC | 10,677 | $452.0K |
| ExodusPoint Capital Management, LP | 9,524 | $403.0K |
| Hexavest Inc. | 8,457 | $357.0K |
| Quantitative Systematic Strategies LLC | 7,547 | $319.0K |
| Vident Investment Advisory, LLC | 4,863 | $206.0K |
| XTX Topco Ltd | 4,853 | $205.0K |
| Gotham Asset Management, LLC | 4,785 | $202.0K |
| Mayflower Financial Advisors, LLC | 4,770 | $202.0K |
| Acadian Asset Management LLC | 1,464 | $62.0K |
| Leonteq Securities AG | 638 | $27.0K |
| Point72 Hong Kong Ltd | 624 | $26.0K |
| Lazard Asset Management LLC | 282 | $11.0K |
| Versant Capital Management, Inc | 17 | $1.00K |
Not filed for Q3 2021 yet (2)
Institutions that held PTC Therapeutics, Inc. at the end of Q2 2021 and haven't filed a 13F for Q3 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Pictet Asset Management Ltd | 459,087 | $19.4M |
| Smith Asset Management Group LP | 70 | $3.00K |